Oral Transmucosal Drugs Market Trends And Overview 2023-2030

Oral Transmucosal Drugs Market Dynamics

Alternative Route in Pandemic:

Oral transmucosal drug administration emerged as an alternative in end-of-life and palliative care during the COVID-19 pandemic. This method involves systemic drug distribution through the oral cavity's mucous membrane, proving practical and user-friendly in palliative care.

Market Growth Drivers:

The global oral transmucosal drugs market is driven by increased autoimmune disorders, cancer cases, and respiratory issues. Technological advancements and key players' research activities on novel oral transmucosal drugs contribute to market expansion.

Download Sample

Oral Transmucosal Drugs Market Dynamics

Incidence Surge in Autoimmune Disorders and Cancer:

The market is poised for growth due to a rise in autoimmune disorders and cancer cases globally. Diseases like oral cancer and autoimmune disorders affect a growing population, boosting the demand for transmucosal drugs, known for preventing gastrointestinal degradation and ensuring rapid action.

Statistics and Demand Correlation:

For instance, the CDC's National Diabetes Statistics Report projected 37.3 million global diabetes cases in 2022, with 11.3% of Americans affected. This prevalence increases the demand for transmucosal medications.

Regulatory Challenges:

Regulatory challenges pose hurdles for transmucosal drug development and commercialization. Rigorous safety and efficacy testing, a prerequisite for regulatory approval, is a key regulatory challenge for transmucosal drugs.

Oral Transmucosal Drugs Market Segment Analysis

Tablets Segment Dominance:

The tablets segment holds a prominent market position, constituting around 47% of the oral transmucosal drugs market share in 2022. Benefits such as quick absorption, ease of administration, minimal interaction with other medications, and considerations for older adults who take multiple medications contribute to the segment's dominance.

Salivary Output Study:

A study published in the National Library of Medicine's Journal in August 2021 highlighted the reduced salivary output in older adults taking multiple medications, emphasizing the significance of oral transmucosal tablets.

Oral Transmucosal Drugs Market Geographical Share

North America's Dominance:

North America holds a substantial share of about 37% in the global oral transmucosal drugs market. Active regional players, drug availability, and opioid use disorders contribute to North America's market dominance.

Opioid Use Disorder Statistics:

As per Stat Pearls, opioid use disorder and addiction remain at pandemic levels in the U.S. and worldwide. Opioid use disorder has affected millions in the U.S., with an insatiable demand for opioid drug prescriptions.

Oral Transmucosal Drugs Market Companies

Key Global Players:

Major players in the market include Pfizer Inc., ZIM Laboratories Limited, Aquestive Therapeutics, Inc, IntelGenx Corp, Indivior PLC, C.L.Pharm Co., Ltd, Seoul Pharmaceuticals, Shilpa Therapeutics, Sunovion Pharmaceuticals, Inc, and CURE Pharmaceutical, among others.

Know More

Relevant Reports:

Meningitis Vaccines Market

DTaP Vaccine Market

DNA Vaccines Market

Antibacterial Drugs Market

Ion Channel Modulators Market

3D Printed Drugs Market

About Us -

DataM Intelligence 4Market Research is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We leverage our top trademark trends, insights, and developments to deliver swift and astute solutions. Our research database features countless statistics and in-depth analyses across a wide range of reports, creating business solutions for companies across the globe.

Contact Us -

Company Name: DataM Intelligence

Email: info@datamintelligence.com

Phone: +1 877 441 4866

Website: DataM Intelligence